Chemoinformaics analysis of 1,3,4,5-TETRACAFFEOYLQUINIC-ACID
| Molecular Weight | 840.743 | nRot | 13 |
| Heavy Atom Molecular Weight | 804.455 | nRig | 39 |
| Exact Molecular Weight | 840.19 | nRing | 5 |
| Solubility: LogS | -2.538 | nHRing | 0 |
| Solubility: LogP | 3.909 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 97 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 61 | No. of Aromatic Carbocycles | 4 |
| nHetero | 18 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 43 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 24 |
| No. of Oxygen atom | 18 | No. of Arom Bond | 24 |
| nHA | 17 | APOL | 110.251 |
| nHD | 9 | BPOL | 47.3995 |
| QED | 0.039 |
| Synth | 4.357 |
| Natural Product Likeliness | 0.917 |
| NR-PPAR-gamma | 0.975 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.169 |
| HIA | 0.949 |
| CACO-2 | -6.415 |
| MDCK | 0.0000173 |
| BBB | 0.012 |
| PPB | 0.999548 |
| VDSS | 0.215 |
| FU | 0.0120398 |
| CYP1A2-inh | 0.222 |
| CYP1A2-sub | 0.01 |
| CYP2c19-inh | 0.308 |
| CYP2c19-sub | 0.033 |
| CYP2c9-inh | 0.291 |
| CYP2c9-sub | 0.226 |
| CYP2d6-inh | 0.043 |
| CYP2d6-sub | 0.142 |
| CYP3a4-inh | 0.043 |
| CYP3a4-sub | 0.135 |
| CL | 6.23 |
| T12 | 0.973 |
| hERG | 0.049 |
| Ames | 0.068 |
| ROA | 0.078 |
| SkinSen | 0.982 |
| Carcinogencity | 0.143 |
| EI | 0.788 |
| Respiratory | 0.009 |
| NR-Aromatase | 0.61 |
| Antiviral | Yes |
| Prediction | 0.945434 |